Thierry Virolle

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 14, 2025
Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038.

Laurent Turchi, Nathalie Sakakini, Gaelle Saviane

|Dec 09, 2023
Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.

David Chardin, Lun Jing, Mélanie Chazal-Ngo-Mai

|Oct 28, 2023
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3.

Laurent Turchi, Nathalie Sakakini, Gaelle Saviane

|Jun 28, 2023
Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring.

Jean Nakhle, Khattar Khattar, Tülin Özkan

|Oct 31, 2022
Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase.

Mirca S Saurty-Seerunghen, Thomas Daubon, Léa Bellenger

Pageof 1

Frequent Collaborators

3 joint publications

Marie-Pierre Junier

3 joint publications

Marie-Luce Vignais

3 joint publications

Laurent Turchi

2 joint publications

Mathieu Gabut